A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children
Status:
COMPLETED
Trial end date:
2024-07-15
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial was to determine if adding ipratropium bromide to salbutamol improves asthma treatment in children.
The main question this study aimed to answer was:
Does combining ipratropium with salbutamol improve asthma symptoms more effectively than salbutamol alone?
Researchers compared salbutamol alone to a combination of salbutamol and ipratropium in children with acute asthma.
Participants:
(i) Received either salbutamol alone or salbutamol with ipratropium via nebulization for 4 hours
(ii) Had their asthma symptoms assessed before and after treatment
(iii) Were discharged with continued treatment and counseling if stable
This study was conducted in the Department of Pediatric Medicine, Children's Hospital Multan, over six months. A total of 60 children with acute asthma were included.
Phase:
PHASE4
Details
Lead Sponsor:
Children's Hospital and Institute of Child Health, Multan